Sagun Proteins Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 11-01-2025
- Paid Up Capital ₹ 1.68 M
as on 11-01-2025
- Company Age 17 Year, 29 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.98 Cr
as on 11-01-2025
- Revenue -34.08%
(FY 2022)
- Profit -29.47%
(FY 2022)
- Ebitda 111.14%
(FY 2022)
- Net Worth 13.82%
(FY 2022)
- Total Assets 10.34%
(FY 2022)
About Sagun Proteins
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.68 M.
The company currently has active open charges totaling ₹1.98 Cr.
Hariom Modi, Deepak Modi, Neeraj Modi, and One other member serve as directors at the Company.
- CIN/LLPIN
U15203MP2007PTC020113
- Company No.
020113
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Morena, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sagun Proteins Private Limited offer?
Sagun Proteins Private Limited offers a wide range of products and services, including Milk & Dairy Products, Milk Proteins.
Who are the key members and board of directors at Sagun Proteins?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Modi  | Director | 21-Aug-2012 | Current |
| Hariom Modi | Director | 18-Dec-2007 | Current |
| Deepak Modi | Director | 18-Dec-2007 | Current |
| Pankaj Modi | Director | 31-Aug-2012 | Current |
Financial Performance of Sagun Proteins.
Sagun Proteins Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 34.08% decrease. The company also saw a substantial fall in profitability, with a 29.47% decrease in profit. The company's net worth Soared by an impressive increase of 13.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sagun Proteins?
In 2021, Sagun Proteins had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sagun Pharma Chemicals Private LimitedActive 2 years 8 monthsHariom Modi, Deepak Modi and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Central Bank Of India Creation Date: 04 Dec 2012 | ₹1.80 M | Open |
Central Bank Of India Creation Date: 04 Dec 2012 | ₹1.80 Cr | Open |
How Many Employees Work at Sagun Proteins?
Unlock and access historical data on people associated with Sagun Proteins, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sagun Proteins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sagun Proteins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
